TUB-010, a novel antibody drug conjugate with reduced nonspecific toxicity profile based on Tub-tag technology widens the therapeutic window of targeting CD30 Meeting Abstract
| Authors: | Gerlach, M.; Schmitt, S.; Cyprys, P.; Kasper, M. A.; Mai, I.; Vermeer, M. H.; Horwitz, S. M.; Fingerle-Rowson, G.; Vogl, A.; Schumacher, D.; Helma-Smets, J. |
| Abstract Title: | TUB-010, a novel antibody drug conjugate with reduced nonspecific toxicity profile based on Tub-tag technology widens the therapeutic window of targeting CD30 |
| Meeting Title: | EORTC CLTG Meeting on Cutaneous Lymphomas: From Molecules to PROs |
| Journal Title: | European Journal of Cancer |
| Volume: | 173 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Sep 22-24 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-09-01 |
| Start Page: | S27 |
| Language: | English |
| ACCESSION: | WOS:000872008600058 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0959-8049(22)00604-9 |
| Notes: | Meeting Abstract: Ther-O-15 -- Oral Presentation: Therapeutics -- Source: Wos |
